Family | Genus | Species | Genome | VSR | Viral strategies to suppress antiviral RNA silencing | References |
---|---|---|---|---|---|---|
Caulimoviridae | Caulimovirus | CaMV | dsDNA | P6 (TAV) | Suppresses RNA silencing by DRB4 inactivation and interference with RDR6-dependent trans-acting and secondary vsiRNA pathways | |
Geminiviridae | Begomovirus | TYLCV | ssDNA | V2 | Suppresses antiviral RNA silencing locally by interacting with SGS3 | |
TYLCCNV | ssDNA | βC1 | Interacts with an endogenous suppressor of RNA silencing (rgsCAM) to inhibit RDR6 expression and secondary siRNA production | Li et al. (2014) | ||
Curtovirus | BCTV | ssDNA | L2/AL2 | Inactivates ADK, suppresses SAMS and SAHH to interfere with the methylation process | ||
Mastrevirus | WDV | ssDNA | Rep | Impedes both local and systemic silencing via 21-nt and 24-nt siRNA binding | Wang et al. (2014) | |
Tospoviridae | Orthotospovirus | GBNV | (−)ssRNA | NSs | Interferes with miRNA biogenesis and suppresses antiviral RNA silencing responses locally | |
GRSV, INSV, TSWV, TYRV | (−)ssRNA | NSs | Binds to dsRNA duplexes, including siRNA and miRNA, and suppresses local and systemic silencing | |||
Phenuiviridae | Tenuivirus | RHBV, RSV | (−)ssRNA | NS3 | Suppresses RNA silencing in plants and insects. Binds to RNA/RNA or RNA/DNA duplexes with a length greater than 9 nt and long ssRNA | |
RSV | (−)ssRNA | P2 | Interacts with SGS3 and enhances PVX pathogenicity | Du et al. (2011) | ||
Rhabdoviridae | Cytorhabdovirus | LNYV | (−)ssRNA | Phosphoprotein (P) | Interacts with protein AGO (1, 2, 4), RDR6, and SGS3 to suppress RISC-mediated cleavage and RNA silencing amplification | Mann et al. (2016) |
Nucleorhabdovirus | RYSV | (−)ssRNA | P6 | Suppresses systemic RNA silencing only via inhibiting RDR6-mediated secondary siRNA biosynthesis and enhancing PVX virulence | Guo et al. (2013) | |
Bromoviridae | Cucumovirus | CMV | (+)ssRNA | 2b | Interacts with RDR proteins, suppresses AGO1 via upregulating miR168, and binds to siRNA as well | |
TAV | (+)ssRNA | 2b | Suppresses RNA silencing through the size-selective binding of siRNA | Chen et al. (2008) | ||
Ilarvirus | AV-2 | (+)ssRNA | 2b | Viral suppressor activity is retained in systemic silencing but not in local silencing | Shimura et al. (2013) | |
Comovirinae | Comovirus | CPMV | (+)ssRNA | CP (S) | C-terminal 16 amino acids of the CP (S) are predominantly essential for VSR activity | Canizares et al. (2004) |
Secoviridae | Nepovirus | ToRSV | (+)ssRNA | CP | Suppresses RNA silencing through AGO1 binding and CP-mediated AGO1 degradation. VSR activity is conserved in the WG motif of CP | Karran and Sanfacon (2014) |
Reoviridae | Phytoreovirus | RDV | dsRNA | PNS10 | Suppresses both local and systemic silencing, enhancing viral replication and stability. Downregulation of RDR6 through binding with siRNA | Ren et al. (2010) |
RGDV | dsRNA | PNS11, PNS12 | PNS11 suppresses RNA silencing through miRNA pathway interference. PNS12 shows nucleus localization and suppresses RNA silencing locally | |||
Oryzavirus | RRSV | dsRNA | PNS6 | It is a local VSR, and ablation of the RNA binding region eliminates suppressor activity. Overexpression enhances PVX pathogenicity in N. benthamiana | Wu et al. (2010) | |
Luteoviridae | Enamovirus | PEMV-1 | (+)ssRNA | P0 | Suppresses local and systemic silencing via destabilization of AGO1 | Fusaro et al. (2012) |
Polerovirus | BWYV, CYDV, CABYV | (+)ssRNA | P0 | Targets AGO proteins through destabilization and the autophagy pathway and suppresses only local silencing | Pazhouhandeh et al. (2006), Baumberger et al. (2007), Bortolamiol et al. (2007) and Derrien et al. (2012) | |
PLRV | (+)ssRNA | P0 | Targets AGO1 and suppresses both local and systemic silencing | Fusaro et al. (2012) | ||
CLRDV, SCYLV | (+)ssRNA | P0 | Suppresses local RNA silencing but not systemic silencing | |||
Potyviridae | Ipomovirus | SPMMV | (+)ssRNA | P1 | Interacts with AGO1 through WG/GW motifs and inhibits si/miRNA-programmed RISC activity | Giner et al. (2010) |
CVYV | (+)ssRNA | P1 | It enhances the VSR activity HC-Pro in members of Potyvirus. Its duplicated form, P1b, down-regulates dsRNA formation and suppresses local RNA silencing | Valli et al. (2006) | ||
Tritimovirus | WSMV | (+)ssRNA | P1 | Suppresses antiviral RNA silencing and downstream GFP siRNA accumulation significantly | Young et al. (2012) | |
Poacevirus | TriMV, SCSMV | (+)ssRNA | P1 | Suppresses dsRNA-triggered systemic silencing more efficiently than HC-Pro of TuMV and enhances the pathogenicity of heterologous virus | Tatineni et al. (2012) | |
Potyvirus | TEV | (+)ssRNA | HC-Pro | Binds to siRNA and inhibits its 3′ methylation, and suppresses AGO1 through miR168 up-regulation | ||
TuMV | (+)ssRNA | HC-Pro | Interacts with RAV2 to restrict primary siRNA biogenesis, and interferes with the miRNA pathway as well | |||
ZYMV | (+)ssRNA | HC-Pro | Binds to siRNA duplexes, interacts and inhibits HEN1 methylation activity | |||
PVY | (+)ssRNA | HC-Pro | Suppresses antiviral RNA silencing through binding with 21–22 nt sRNA of viral sequences | Del Toro et al. (2017) | ||
SCMV | (+)ssRNA | HC-Pro | Down-regulates the accumulation of secondary siRNAs and suppresses both sense RNA and dsRNA-induced silencing | Zhang et al. (2008) | ||
PVA | (+)ssRNA | HC-Pro, VPg | HC-Pro interferes with host gene expression (SAHH) and interrupts the methionine cycle to suppress RNA silencing. VPg demonstrates SGS3 interaction | |||
PRSV | (+)ssRNA | HC-Pro | Interferes with the miRNA pathway and downregulates AGO1 via miR168 upregulation | Azad et al. (2014) | ||
PPV | (+)ssRNA | HcPro-P1 | Enhances silencing suppression in a synergistic form (HcPro-P1) | Valli et al. (2006) | ||
Rymovirus | AgMV, HoMV | (+)ssRNA | HC-Pro | Suppresses RNA silencing with tritimoviruses P1 while its VSR function is still unclear | Young et al. (2012) | |
Tombusviridae | Aureusvirus | PoLV | (+)ssRNA | P14 | Binds to dsRNAs without size selection and suppresses silencing through sequestering dsRNAs and ds siRNAs | Merai et al. (2005) |
Tombusvirus | CIRV | (+)ssRNA | P19 | Suppresses RNA silencing via binding with siRNA and hampering the 3′ methylation of siRNAs | ||
CymRSV | (+)ssRNA | P19 | Silencing suppression through AGO1 repression via miR168 upregulation and binding silencing-generated 21–25 nt dsRNA size dependently | |||
TBSV | (+)ssRNA | P19 | Suppresses antiviral RNA silencing via interacting miRNA pathways at the intermediate level, including miRNA methylation | |||
CNV | (+)ssRNA | P20 | Its VSR activity is quite similar to TBSV p19 but 50-fold lower than p19 | Hao et al. (2011) | ||
Carmovirus | TCV | (+)ssRNA | P38 | Targets AGO1 through GW-motifs and modifies DCL usage by increasing DCL1 levels, resulting in considerable DCL3 and DCL4 downregulation. Binds to dsRNA size independently and interferes with primary siRNA biogenesis (effect dependent on interaction with RAV2) | Merai et al. (2006), Azevedo et al. (2010) and Endres et al. (2010) | |
PFBV, HCRSV, PLPV | (+)ssRNA | CP/ P37 | Binds to siRNAs and suppresses RNA silencing with the enhancement of PVX pathogenicity. Mutations in the GW motif affects siRNA binding capability | Meng et al. (2006), Martinez-Turino and Hernandez (2009) and Perez-Canamas and Hernandez (2015) | ||
MNSV | (+)ssRNA | P7B, P42 | P7B delays RNA silencing. P42 enhances local spread similar to that of potyviral HC-Pro, probably because of its VSR activity | Genoves et al. (2006) | ||
Dianthovirus | RCNMV | (+)ssRNA | MP | It is an unknown DCL1 dependent MP and interferes with miRNA biogenesis | Takeda et al. (2005) | |
Closteroviridae | Ampelovirus | GLRaV-3 | (+)ssRNA | P19.7 | Impedes RNA silencing through siRNA and miRNA pathway interference | |
PMWaV-1,-2 | (+)ssRNA | P61, CP, P20 | P61 suppresses RNA silencing systemically, CP subdues both local and systemic silencing, and P20 affects dsRNA-induced local silencing | Dey et al. (2015) | ||
Closterovirus | BYV | (+)ssRNA | P21 | Interacts with 21 nt or longer ssRNAs and dsRNAs and suppresses dsRNA-induced silencing of GFP mRNA and blocks HEN1 methyltransferase | Reed et al. (2003), Lu et al. (2004) and Ye and Patel (2005) | |
CTV | (+)ssRNA | CP, P20, P23 | CP and p20 suppress antiviral RNA silencing pathways at the intercellular level, while P23 does so at the intracellular level | Lu et al. (2004), Fagoaga et al. (2011) and Benitez-Galeano et al. (2015) | ||
RLRaV | (+)ssRNA | P17 | Suppresses antiviral RNA silencing in wild roses | He et al. (2015) | ||
Crinivirus | CYSDV | (+)ssRNA | P25 | Inhibits siRNA accumulation and suppresses dsRNA- or ssRNA-induced silencing of GFP mRNA | Kataya et al. (2009) | |
CCYV | (+)ssRNA | P22 | Binds with CsSKP1LB and suppresses antiviral RNA silencing | Chen et al. (2019) | ||
SPCSV | (+)ssRNA | RNase3, P22 | RNase3 displays endonuclease activity and cleaves siRNAs, but the P22 silencing strategy is still elusive | |||
LCV | (+)ssRNA | P23 | Enhances degradation of siRNAs and suppresses silencing | Kubota and Ng (2016) | ||
ToCV | (+)ssRNA | P22, CP, CPm | P22 counteracts RDR6-mediated antiviral response, CP induces SAHH-interaction, and CPm silencing mechanism is unidentified | Canizares et al. (2008), Landeo-Rios et al. (2016a) and Liu et al. (2021) | ||
TICV | (+)ssRNA | P27 | Suppresses S-PTGS and IR-PTGS | Mashiko et al. (2019) | ||
Virgaviridae | Hordeivirus | BSMV, PSLV | (+)ssRNA | γB | Suppresses RNA silencing by preferentially binding to siRNA size selectively | |
Pecluvirus | PCV | (+)ssRNA | P15 | Binds to siRNA size selectively and interferes with the miRNA pathway to suppress antiviral silencing | ||
Tobamovirus | ORMV | (+)ssRNA | P126 | Interferes with the methylation pathway mediated by HEN1 and the accumulation of novel miRNA-like sRNAs | Vogler et al. (2007) | |
TMV | (+)ssRNA | P126, P122 | P126 mechanism of suppression is unclear, while P122 suppresses RNA silencing through siRNA and miRNA binding and downregulates AGO1 via upregulation of miR168 | |||
ToMV | (+)ssRNA | P130 | Suppresses silencing signals through siRNA binding | Kubota et al. (2003) | ||
Tobravirus | TRV | (+)ssRNA | 16 K | Blocks local silencing via down streaming of dsRNA biogenesis | Martinez-Priego et al. (2008) | |
Furovirus | CWMV, SBWMV | (+)ssRNA | 19 K (CRP) | Suppresses silencing signal, thereby enhancing PVX pathogenicity, and interacts with N-ext/CP | ||
Benyviridae | Benyvirus | BNYVV, BSBMV | (+)ssRNA | P14 | Its VSR activity requires both ZF and NoLS basic residues | Chiba et al. (2013) |
BNYVV | (+)ssRNA | P31 | Plays a role in root-specific silencing suppression and interacts with PR-10 | |||
Tymoviridae | Tymovirus | TYMV | (+)ssRNA | P69 | Inhibits DNA methylation, boosting miRNA and DCL1 upregulation | Chen et al. (2004) |
CVB | (+)ssRNA | P12 | Its VSR activity is ZF domain-dependent but independent of NLS. Promotes PVX infection | Lukhovitskaya et al. (2014) | ||
Alphaflexiviridae | Potexvirus | PVX, PlAMV, PepMV | (+)ssRNA | P25 (TGBp1) | Suppresses RNA silencing via degrading RNA silencing effector nuclease AGO1, co-aggregation with SGS3/RDR6, CAT1 interaction, and X-body organization | Chiu et al. (2010), Tilsner et al. (2012), Mathioudakis et al. (2013) and Okano et al. (2014) |
PepMV | (+)ssRNA | CP | Sequesters silencing signals by inhibiting systemic signaling | Mathioudakis et al. (2014) | ||
Betaflexiviridae | Carlavirus | PVM | (+)ssRNA | CRP, TGBp1 | TGBp1 suppresses merely systemic silencing, whereas CRP inhibits both local and systemic silencing | Senshu et al. (2011) |
SPCFV | (+)ssRNA | NaBp | Suppresses local and systemic silencing, mediated by either sense or dsRNA molecules | Deng et al. (2015) | ||
Trichovirus | ACLSV | (+)ssRNA | P50 | Suppresses silencing systemically, probably by preventing the movement of silencing signals | Yaegashi et al. (2007) | |
Vitivirus | GVA | (+)ssRNA | P10 | Suppresses local and systemic silencing by siRNA binding | Zhou et al. (2006) | |
Citrivirus | CLBV | (+)ssRNA | MP | Interferes with silencing pathways via downregulating the biogenesis of dsRNA and siRNA | Renovell et al. (2012) | |
Solemoviridae | Sobemovirus | RYMV | (+)ssRNA | P1 | Suppresses RNA silencing through reduction of 21–24 nt siRNAs and deregulation of DCL4‐dependent endogenous siRNA pathways | Lacombe et al. (2010) |
CfMV | (+)ssRNA | P1, CP | P1 shows weak systematic suppression without siRNA binding, while CP suppresses antiviral RNA silencing, but the mechanism of suppression is not clear |